Jiangsu Aidea Pharmaceutical Group Co., Ltd.SSE: 688488

Notice on Convening the 1st Extraordinary General Meeting in 2026

· Issued by Jiangsu Aidea Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 6 pages · Chinese

Summary by 6ix AI

The meeting is scheduled to take place in late June and will include both on-site and online voting options for shareholders. Key agenda items for the meeting include proposals for revising the company's remuneration management system and the reappointment of the accounting firm. The notice outlines the registration process and voting procedures for shareholders wishing to participate in the meeting.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Notice on Convening the 1st Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Jiangsu Aidea Pharmaceutical Group Co., Ltd. on 6ix

Earlier from Jiangsu Aidea Pharmaceutical

Later from Jiangsu Aidea Pharmaceutical

All Jiangsu Aidea Pharmaceutical news releases